Neuromorphic Electrical Stimulation Systems for Personalized Bone Healing and Pain Management

Publication ID: 24-11857785_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Neuromorphic Electrical Stimulation Systems for Personalized Bone Healing and Pain Management,” Published Technical Disclosure No. 24-11857785_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857785_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,785.

Summary of the Inventive Concept

This inventive concept discloses next-generation electrical stimulation systems that leverage cognitive computing, digital twins, swarm intelligence, AI-driven platforms, and biohybrid components to revolutionize bone healing and pain management. These systems adapt to individual patient needs, optimize therapeutic outcomes, and offer unprecedented levels of personalization and efficacy.

Background and Problem Solved

The original patent's non-invasive transcutaneous electrical stimulation devices have limitations in terms of adaptability, precision, and efficacy. The new inventive concept addresses these limitations by integrating cutting-edge technologies to create a paradigm shift in electrical stimulation therapy, enabling real-time adaptation, precision targeting, and optimal therapeutic outcomes.

Detailed Description of the Inventive Concept

The inventive concept encompasses four key aspects: 1) a neuromorphic stimulation system with cognitive computing, which adapts stimulation protocols based on patient outcomes; 2) a method for personalized electrical stimulation therapy using digital twins and simulation; 3) a wearable, implantable, or transcutaneous device with swarm intelligence, which coordinates stimulation pulses for synchronized electromagnetic fields; and 4) an AI-driven platform with cloud-based analysis and mobile application feedback. The biohybrid electrical stimulation system incorporates genetically engineered living tissue components to enhance bone healing and tissue regeneration.

Novelty and Inventive Step

The new claims introduce unprecedented levels of adaptability, precision, and personalization through the integration of cognitive computing, digital twins, swarm intelligence, AI-driven platforms, and biohybrid components. These innovations overcome the limitations of the original patent, providing a novel and non-obvious approach to electrical stimulation therapy.

Alternative Embodiments and Variations

Alternative embodiments could include the use of edge computing, blockchain, or quantum computing to enhance the system's adaptability and security. Variations may include the application of these technologies to other therapeutic areas, such as wound healing, pain management, or neurological disorders.

Potential Commercial Applications and Market

The inventive concept has vast commercial potential in the medical device industry, particularly in the areas of orthopedics, pain management, and regenerative medicine. The market for electrical stimulation devices is expected to grow significantly, driven by the increasing demand for personalized and effective therapeutic solutions.

Original Patent Information

Patent NumberUS 11,857,785
TitleSystems, methods and devices for electrical stimulation therapy
Assignee(s)Theragen, Inc.